SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Regenerative Medicine

PUBLISHER: Grand View Research | PRODUCT CODE: 2132236

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2132236

Induced Pluripotent Stem Cells Market Size, Share & Trends Analysis Report By Derived Cell Type, By Application, By End Use, By Region, And Segment Forecasts, 2026 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Induced Pluripotent Stem Cells Market Summary

The global induced pluripotent stem cells market size was valued at USD 2.0 billion in 2025 and is projected to grow from USD 2.2 billion in 2026 to USD 4.8 billion by 2033, at a CAGR of 11.8% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 35.8% in 2025. The rising prevalence of chronic diseases, increasing research and development activities in stem cell therapies, and growing focus on personalized medicine drive the iPSC market growth.

Global Induced Pluripotent Stem Cells Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global induced pluripotent stem cells market on the basis of derived cell type, application, end use, and region:

  • Derived Cell Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Hepatocytes
  • Fibroblasts
  • Keratinocytes
  • Amniotic Cells
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Development
  • Tissue Engineering & Regenerative Medicine
    • Neurology
    • Orthopedics
    • Oncology
    • Cardiovascular and Myocardial Infraction
    • Diabetes
    • Others
  • Toxicology Research
  • Disease Modeling
  • End use Outlook (Revenue, USD Million, 2021 - 2033)
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68040-116-1

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Derived Cell Type Segment
      • 1.1.1.2. Application Segment
      • 1.1.1.3. End-use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis:
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. List of Secondary Sources
    • 1.9.3. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing Application of Regenerative Medicine
      • 3.2.1.2. Technology Advancement in iPSC Production
      • 3.2.1.3. Growing Prevalence of Chronic and Degenerative Diseases
      • 3.2.1.4. Expanding Applications in Disease Modeling and Drug Discovery
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent Process Control and Regulatory Challenges
      • 3.2.2.2. Challenges in Large-Scale Commercialization and Reproducibility
      • 3.2.2.3. High Cost of Production
    • 3.2.3. Market Opportunities Analysis
    • 3.2.4. Market Challenges Analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Economic landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Derived Cell Type Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Induced Pluripotent Stem Cells Market: Derived Cell Type Movement Analysis
  • 4.3. Hepatocytes
    • 4.3.1. Hepatocytes Market, 2021 - 2033 (USD Million)
  • 4.4. Fibroblasts
    • 4.4.1. Fibroblasts Market, 2021 - 2033 (USD Million)
  • 4.5. Keratinocytes
    • 4.5.1. Keratinocytes Market, 2021 - 2033 (USD Million)
  • 4.6. Amniotic Cells
    • 4.6.1. Amniotic Cells Market, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Induced Pluripotent Stem Cells Market: Application Movement Analysis
  • 5.3. Drug Development
    • 5.3.1. Drug Development Market, 2021 - 2033 (USD Million)
  • 5.4. Tissue Engineering & Regenerative Medicine
    • 5.4.1. Tissue Engineering & Regenerative Medicine Market, 2021 - 2033 (USD Million)
    • 5.4.2. Neurology
      • 5.4.2.1. Neurology Market, 2021 - 2033 (USD Million)
    • 5.4.3. Orthopedics
      • 5.4.3.1. Orthopedics Market, 2021 - 2033 (USD Million)
    • 5.4.4. Oncology
      • 5.4.4.1. Oncology Market, 2021 - 2033 (USD Million)
    • 5.4.5. Cardiovascular and Myocardial Infarction
      • 5.4.5.1. Cardiovascular and Myocardial Infarction Market, 2021 - 2033 (USD Million)
    • 5.4.6. Diabetes
      • 5.4.6.1. Diabetes Market, 2021 - 2033 (USD Million)
    • 5.4.7. Others
      • 5.4.7.1. Others Market, 2021 - 2033 (USD Million)
  • 5.5. Toxicology Research
    • 5.5.1. Toxicology Research Market, 2021 - 2033 (USD Million)
  • 5.6. Disease Modeling
    • 5.6.1. Disease Modeling Market, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Induced Pluripotent Stem Cells Market: End-use Movement Analysis
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Induced Pluripotent Stem Cells Market Share By Region, 2025 & 2033
  • 7.2. North America
    • 7.2.1. North America Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. U.S. Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Canada Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Competitive Scenario
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Mexico Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. UK Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Germany Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. France Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Italy Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Spain Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Denmark Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Sweden Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Norway Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Japan Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. China Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. India Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Australia Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Thailand Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. South Korea Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Brazil Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Argentina Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. South Africa Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Saudi Arabia Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. UAE Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Kuwait Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Company Market Share/ Position Analysis, 2025
  • 8.3. Strategy Mapping
  • 8.4. Company Profiles/Listing
    • 8.4.1. STEMCELL Technologies Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Cellular Engineering Technologies Inc.
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. REPROCELL Inc.
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Takara Bio, Inc.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Axol Bioscience Ltd.
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Fate Therapeutics, Inc.
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. FUJIFILM Cellular Dynamics, Inc.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Cynata Therapeutics Limited
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Evotec SE
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Astellas Pharma Inc.
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
Show more
Product Code: GVR-4-68040-116-1

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 4 Global induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 5 Global induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 6 Global induced pluripotent stem cells market, by region, 2021 - 2033 (USD Million)
  • Table 7 North America induced pluripotent stem cells market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 9 North America induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 10 North America induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 11 U.S. induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 12 U.S. induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 13 U.S. induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 14 Canada induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 15 Canada induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 16 Canada induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 17 Mexico induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 18 Mexico induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 19 Mexico induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 20 Europe induced pluripotent stem cells market, by country, 2021 - 2033 (USD Million)
  • Table 21 Europe induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 22 Europe induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 23 Europe induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 24 UK induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 25 UK induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 26 UK induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 27 Germany induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 28 Germany induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 29 Germany induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 30 France induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 31 France induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 32 France induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 33 Italy induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 34 Italy induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 35 Italy induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 36 Spain induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 37 Spain induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 38 Spain induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 39 Denmark induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 40 Denmark induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 41 Denmark induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 42 Sweden induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 43 Sweden induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 44 Sweden induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 45 Norway induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 46 Norway induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 47 Norway induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific induced pluripotent stem cells market, by country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 52 Japan induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 53 Japan induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 54 Japan induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 55 China induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 56 China induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 57 China induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 58 India induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 59 India induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 60 India induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 61 Australia induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 62 Australia induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 63 Australia induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 64 Thailand induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 65 Thailand induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 66 Thailand induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 67 South Korea induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 68 South Korea induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 69 South Korea induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 70 Latin America induced pluripotent stem cells market, by country, 2021 - 2033 (USD Million)
  • Table 71 Latin America induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 72 Latin America induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 73 Latin America induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 74 Brazil induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 75 Brazil induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 76 Brazil induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 77 Argentina induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 78 Argentina induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 79 Argentina induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa induced pluripotent stem cells market, by country, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 83 Middle East & Africa induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 84 South Africa induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 85 South Africa induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 86 South Africa induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 90 UAE induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 91 UAE induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 92 UAE induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 93 Kuwait induced pluripotent stem cells market, by derived cell type, 2021 - 2033 (USD Million)
  • Table 94 Kuwait induced pluripotent stem cells market, by application, 2021 - 2033 (USD Million)
  • Table 95 Kuwait induced pluripotent stem cells market, by end-use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Induced pluripotent stem cells market segmentation
  • Fig. 8 Market snapshot, 2025
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTLE analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Market penetration & growth prospect mapping, 2025
  • Fig. 15 Global Induced Pluripotent Stem Cells Market: Derived cell type movement analysis
  • Fig. 16 Global Induced Pluripotent Stem Cells Market, for Hepatocytes, 2021 - 2033 (USD Million)
  • Fig. 17 Global Induced Pluripotent Stem Cells Market, for Fibroblasts, 2021 - 2033 (USD Million)
  • Fig. 18 Global Induced Pluripotent Stem Cells Market, for Keratinocytes, 2021 - 2033 (USD Million)
  • Fig. 19 Global Induced Pluripotent Stem Cells Market, for Amniotic Cells, 2021 - 2033 (USD Million)
  • Fig. 20 Global Induced Pluripotent Stem Cells Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 21 Global Induced Pluripotent Stem Cells Market: Application movement analysis
  • Fig. 22 Global Induced Pluripotent Stem Cells Market, for Drug Development and Discovery, 2021 - 2033 (USD Million)
  • Fig. 23 Global Induced Pluripotent Stem Cells Market, for Tissue Engineering & Regenerative Medicine, 2021 - 2033 (USD Million)
  • Fig. 24 Global Induced Pluripotent Stem Cells Market, for Neurology, 2021 - 2033 (USD Million)
  • Fig. 25 Global Induced Pluripotent Stem Cells Market, for Orthopedics, 2021 - 2033 (USD Million)
  • Fig. 26 Global Induced Pluripotent Stem Cells Market, for Oncology, 2021 - 2033 (USD Million)
  • Fig. 27 Global Induced Pluripotent Stem Cells Market, for Cardiovascular and Myocardial Infraction, 2021 - 2033 (USD Million)
  • Fig. 28 Global Induced Pluripotent Stem Cells Market, for Diabetes, 2021 - 2033 (USD Million)
  • Fig. 29 Global Induced Pluripotent Stem Cells Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 30 Global Induced Pluripotent Stem Cells Market, for Toxicology Studies, 2021 - 2033 (USD Million)
  • Fig. 31 Global Induced Pluripotent Stem Cells Market, for Disease Modeling, 2021 - 2033 (USD Million)
  • Fig. 32 Global Induced Pluripotent Stem Cells Market: End-use movement analysis
  • Fig. 33 Global Induced Pluripotent Stem Cells Market, for Research and Academic Institutes, 2021 - 2033 (USD Million)
  • Fig. 34 Global Induced Pluripotent Stem Cells Market, for Biotechnology & Pharmaceutical Companies, 2021 - 2033 (USD Million)
  • Fig. 35 Global Induced Pluripotent Stem Cells Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 36 Regional marketplace: Key takeaways
  • Fig. 37 Regional outlook, 2025 & 2033
  • Fig. 38 Global Induced Pluripotent Stem Cells Market: Region movement analysis
  • Fig. 39 North America Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 40 U.S. Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 41 Canada Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 42 Mexico Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 43 Europe Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 44 Germany Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 45 UK Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 46 France Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 47 Italy Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 48 Spain Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 49 Denmark Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 50 Sweden Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 51 Norway Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 52 Asia Pacific Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 53 Japan Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 54 China Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 55 India Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 56 Australia Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 57 South Korea Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 58 Thailand Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 59 Latin America Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 60 Brazil Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 61 Argentina Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 62 Middle East and Africa Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 63 South Africa Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 64 Saudi Arabia Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 65 UAE Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 66 Kuwait Induced Pluripotent Stem Cells Market, 2021 - 2033 (USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!